Search Results

You are looking at 101 - 110 of 535 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Benjamin O. Anderson

histopathologists in each medical community, and the training and experience of the available pathology specialists in relation to breast diagnosis. 4 At the same time, it is useful to consider how effective systems can be designed and implemented when these

Full access

Matthew D. Galsky, Harry W. Herr, and Dean F. Bajorin

: 3020 – 3028 . 4 Herr HW : Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality) . BJU Int 2003 ; 92 : 187 – 188 . 5 Herr HW : Extent of surgery and pathology evaluation has an impact on bladder

Full access

Rahel Demisse, Neha Damle, Edward Kim, Jun Gong, Marwan Fakih, Cathy Eng, Leslie Oesterich, Madison McKenny, Jingran Ji, James Liu, Ryan Louie, Kit Tam, Sepideh Gholami, Wissam Halabi, Arta Monjazeb, Farshid Dayyani, and May Cho

brachytherapy) presented with rectal bleeding. His workup, including colonoscopy, revealed 2 large masses in the rectum with central ulceration. Pathology was significant for moderately to poorly differentiated invasive adenocarcinoma with loss of MSH2 and MSH6

Full access

Nathan J. Moore, Megan Othus, Anna B. Halpern, Nicholas P. Howard, Linyi Tang, Kyle E. Bastys, Mary-Elizabeth M. Percival, Paul C. Hendrie, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey, and Roland B. Walter

typing; (4) laboratory charges, including all non–transfusion-related laboratory studies such as blood counts, basic metabolic panels, and lung function tests; microbiology including blood, sputum, and urine cultures; and pathology including tissue

Full access

Kamel Izeradjene and Sunil R. Hingorani

Cancer Res 2000 ; 6 : 2969 – 2972 . 7. Hruban RH Iacobuzio-Donahue C Wilentz RE . Molecular pathology of pancreatic cancer . Cancer J 2001 ; 7 : 251 – 258 . 8. Kahn S Yamamoto F Almoguera C . The c-K-ras gene and human cancer

Full access

Nikolaos A. Trikalinos, Amy Zhou, Maria B. Majella Doyle, Kathryn J. Fowler, Ashley Morton, Neeta Vachharajani, Manik Amin, Jesse W. Keller, William C. Chapman, Elizabeth M. Brunt, and Benjamin R. Tan

–approved Washington University Liver Cancer Registry. The registry has a retrospective and prospective component and collects information on consenting patients with various liver pathologies. We identified 123 patients with histopathologically proven cHCC-CCA in the

Full access

Karisa C. Schreck, Andrew Guajardo, Doris D.M. Lin, Charles G. Eberhart, and Stuart A. Grossman

presented with focal seizures and a left temporal lobe mass in 1998, which was observed until 2002 when he underwent surgery, and pathology results showed PXA. He underwent a second surgery in 2004 after demonstrating progression, with pathology still

Full access

Stephanie Alimena, Suvidya Lakshmi Pachigolla, Sarah Feldman, David Yang, Peter F. Orio III, Larissa Lee, and Martin King

disparities were further assessed by determining rates of adverse pathology (eg, positive margins or pathologic nodal involvement) among Black and non-Black women who received surgery to determine if rates of postoperative RT differed by race. Completion of RT

Full access

Presenter: Jennifer J.D. Morrissette

generated and how to use them will be the most important aspect in getting the most out of genomic testing in treating your patients,” Jennifer J.D. Morrissette, PhD, Associate Professor, Department of Clinical Pathology and Laboratory Medicine, and

Full access

Ashley E. Ross

E. Ross, MD, PhD, of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Ross, Assistant Professor of Urology, Oncology, and Pathology, reviewed the evidence supporting the validity of currently available molecular prognostic tests